Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 1
1981 2
1982 1
1989 1
1990 1
1991 1
1993 1
1994 3
1995 8
1996 4
1997 7
1998 10
1999 6
2000 14
2001 15
2002 14
2003 14
2004 18
2005 12
2006 23
2007 20
2008 15
2009 13
2010 19
2011 24
2012 18
2013 36
2014 24
2015 33
2016 19
2017 29
2018 35
2019 47
2020 36
2021 41
2022 34
2023 29
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

575 results

Results by year

Filters applied: . Clear all
Page 1
Calciphylaxis: Diagnosis, Pathogenesis, and Treatment.
Chang JJ. Chang JJ. Adv Skin Wound Care. 2019 May;32(5):205-215. doi: 10.1097/01.ASW.0000554443.14002.13. Adv Skin Wound Care. 2019. PMID: 31008757 Review.
Recognize the pathogenesis and clinical features of and risk factors for calciphylaxis.2. Explain the diagnosis and management of a patient with calciphylaxis. ...This article is a narrative review summarizing the clinical features, diagnosis, pathogenesis, and trea …
Recognize the pathogenesis and clinical features of and risk factors for calciphylaxis.2. Explain the diagnosis and management of a p …
Calciphylaxis: Part I. Diagnosis and pathology.
Rick J, Strowd L, Pasieka HB, Saardi K, Micheletti R, Zhao M, Kroshinsky D, Shinohara MM, Ortega-Loayza AG. Rick J, et al. J Am Acad Dermatol. 2022 May;86(5):973-982. doi: 10.1016/j.jaad.2021.10.064. Epub 2022 Feb 1. J Am Acad Dermatol. 2022. PMID: 35114300 Review.
Calciphylaxis is an uncommon but devastating disorder characterized by vascular calcification and subsequent cutaneous tissue necrosis. ...The goal of this article is to update practicing dermatologists on the current standard of care for calciphylaxis....
Calciphylaxis is an uncommon but devastating disorder characterized by vascular calcification and subsequent cutaneous tissue necrosi …
Calciphylaxis: risk factors, diagnosis, and treatment.
Nigwekar SU, Kroshinsky D, Nazarian RM, Goverman J, Malhotra R, Jackson VA, Kamdar MM, Steele DJ, Thadhani RI. Nigwekar SU, et al. Am J Kidney Dis. 2015 Jul;66(1):133-46. doi: 10.1053/j.ajkd.2015.01.034. Epub 2015 May 7. Am J Kidney Dis. 2015. PMID: 25960299 Free PMC article. Review.
Calciphylaxis is a rare but devastating condition that has continued to challenge the medical community since its early descriptions in the scientific literature many decades ago. ...We hereby provide a summary of recommendations developed by a multidisciplinary team for p …
Calciphylaxis is a rare but devastating condition that has continued to challenge the medical community since its early descriptions …
Calciphylaxis: Treatment and outlook-CME part II.
Rick J, Rrapi R, Chand S, Shinohara MM, Strowd L, Pasieka HB, Micheletti R, Kroshinsky D, Ortega-Loayza AG. Rick J, et al. J Am Acad Dermatol. 2022 May;86(5):985-992. doi: 10.1016/j.jaad.2021.10.063. Epub 2022 Feb 22. J Am Acad Dermatol. 2022. PMID: 35202773 Review.
Calciphylaxis is a rare and devastating condition with important systemic ramifications. This second-part of our CME aims to educate the practicing dermatologist on the current standard of care once a diagnosis of calciphylaxis is confirmed or highly suspected. The …
Calciphylaxis is a rare and devastating condition with important systemic ramifications. This second-part of our CME aims to educate …
Calciphylaxis and Kidney Disease: A Review.
Gallo Marin B, Aghagoli G, Hu SL, Massoud CM, Robinson-Bostom L. Gallo Marin B, et al. Am J Kidney Dis. 2023 Feb;81(2):232-239. doi: 10.1053/j.ajkd.2022.06.011. Epub 2022 Aug 12. Am J Kidney Dis. 2023. PMID: 35970430 Review.
However, calciphylaxis remains a diagnosis that may be clinically challenging to make. ...We also discuss the unique histopathological features of calciphylaxis and contrast it with those of other forms of general vessel calcification. ...
However, calciphylaxis remains a diagnosis that may be clinically challenging to make. ...We also discuss the unique histopathologica …
Calciphylaxis.
Nigwekar SU, Thadhani R, Brandenburg VM. Nigwekar SU, et al. N Engl J Med. 2018 May 3;378(18):1704-1714. doi: 10.1056/NEJMra1505292. N Engl J Med. 2018. PMID: 29719190 Review. No abstract available.
Calciphylaxis.
Nigwekar SU. Nigwekar SU. Curr Opin Nephrol Hypertens. 2017 Jul;26(4):276-281. doi: 10.1097/MNH.0000000000000328. Curr Opin Nephrol Hypertens. 2017. PMID: 28375870 Free PMC article. Review.
PURPOSE OF REVIEW: Calciphylaxis remains a poorly understood vascular calcification disorder with predilection for patients with end-stage renal disease (ESRD). ...SUMMARY: The present review describes recent literature in the field of calciphylaxis. Calciphylaxi …
PURPOSE OF REVIEW: Calciphylaxis remains a poorly understood vascular calcification disorder with predilection for patients with end- …
Intravenous Sodium Thiosulphate for Calciphylaxis of Chronic Kidney Disease: A Systematic Review and Meta-analysis.
Wen W, Portales-Castillo I, Seethapathy R, Durant O, Mengesha B, Krinsky S, Kroshinsky D, Kalim S, Goverman J, Nazarian RM, Chitalia V, Malhotra R, Kramann R, Malhotra CK, Nigwekar SU. Wen W, et al. JAMA Netw Open. 2023 Apr 3;6(4):e2310068. doi: 10.1001/jamanetworkopen.2023.10068. JAMA Netw Open. 2023. PMID: 37099293 Free PMC article.
IMPORTANCE: Calciphylaxis is a rare disease with high mortality mainly involving patients with chronic kidney disease (CKD). ...CONCLUSIONS AND RELEVANCE: Intravenous STS was not associated with skin lesion improvement or survival benefit in patients with CKD experiencing …
IMPORTANCE: Calciphylaxis is a rare disease with high mortality mainly involving patients with chronic kidney disease (CKD). ...CONCL …
Mimics of vasculitis.
Maningding E, Kermani TA. Maningding E, et al. Rheumatology (Oxford). 2021 Jan 5;60(1):34-47. doi: 10.1093/rheumatology/keaa495. Rheumatology (Oxford). 2021. PMID: 33167039 Review.
Genetic disorders and vasculopathies are important considerations in large and medium vessel vasculitis. Cholesterol emboli, thrombotic conditions and calciphylaxis typically affect the medium and small vessels and, like vasculitis, can cause cutaneous, renal and CNS manif …
Genetic disorders and vasculopathies are important considerations in large and medium vessel vasculitis. Cholesterol emboli, thrombotic cond …
An Update on Calciphylaxis.
García-Lozano JA, Ocampo-Candiani J, Martínez-Cabriales SA, Garza-Rodríguez V. García-Lozano JA, et al. Am J Clin Dermatol. 2018 Aug;19(4):599-608. doi: 10.1007/s40257-018-0361-x. Am J Clin Dermatol. 2018. PMID: 29808451 Review.
The pathogenesis remains unclear, and the development of calciphylaxis lesions depends on medial calcification, intimal fibrosis of arterioles and thrombotic occlusion. Despite an increase in reports of calciphylaxis in the literature and clinical recognition of dem …
The pathogenesis remains unclear, and the development of calciphylaxis lesions depends on medial calcification, intimal fibrosis of a …
575 results